Nanotechnology in Cancer Diagnosis and Treatment
Pharmaceutics · 22.03.2023 · 15 (3) · 1025
DOI: 10.3390/pharmaceutics15031025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 22.03.2023. Verfasst von Noor Alrushaid und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stem Cell Biology, Institute for Research and Medical Consultations, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 3144…. Die Arbeit wurde bisher 189-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Traditional cancer diagnosis has been aided by the application of nanoparticles (NPs), which have made the process easier and faster. NPs possess exceptional properties such as a larger surface area, higher volume proportion, and better targeting capabilities. Additionally, their low toxic effect on healthy cells enhances their bioavailability and t-half by allowing them to functionally penetrate the fenestration of epithelium and tissues. These particles have attracted attention in multidisciplinary areas, making them the most promising materials in many biomedical applications, especially in the treatment and diagnosis of various diseases. Today, many drugs are presented or coated with nanoparticles for the direct targeting of tumors or diseased organs without harming normal tissues/cells. Many types of nanoparticles, such as metallic, magnetic, polymeric, metal oxide, quantum dots, graphene, fullerene, liposomes, carbon nanotubes, and dendrimers, have potential applications in cancer treatment and diagnosis. In many studies, nanoparticles have been reported to show intrinsic anticancer activity due to their antioxidant action and cause an inhibitory effect on the growth of tumors. Moreover, nanoparticles can facilitate the controlled release of drugs and increase drug release efficiency with fewer side effects. Nanomaterials such as microbubbles are used as molecular imaging agents for ultrasound imaging. This review discusses the various types of nanoparticles that are commonly used in cancer diagnosis and treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Stem Cell Biology, Institute for Research and Medical Consultations, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.
- Univ. Lyon, University Claude Bernard Lyon-1, CNRS, ISA-UMR 5280, 69622 Lyon, France.
- Biology Department, College of Science, Institute of Research & Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.
ORCID-Profile: Firdos Alam Khan, Ebtesam Abdullah Al-Suhaimi, Abdelhamid Elaissari
Zitieren
APA
Alrushaid, N., Khan, F. A., Al-Suhaimi, E. A., & Elaissari, A. (2023). Nanotechnology in Cancer Diagnosis and Treatment. Pharmaceutics, 15(3), 1025. https://doi.org/10.3390/pharmaceutics15031025
Vancouver
Alrushaid N, Khan FA, Al-Suhaimi EA, Elaissari A. Nanotechnology in Cancer Diagnosis and Treatment. Pharmaceutics. 2023;15(3):1025. doi:10.3390/pharmaceutics15031025
BibTeX
@article{Alrushaid2023,
author = {Alrushaid, Noor and Khan, Firdos Alam and Al-Suhaimi, Ebtesam Abdullah and Elaissari, Abdelhamid},
title = {Nanotechnology in Cancer Diagnosis and Treatment},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {3},
pages = {1025},
doi = {10.3390/pharmaceutics15031025}
}
EUVIMED